Outcomes of Early Sodium-Glucose Cotransporter Two Inhibitor Use in Takotsubo Syndrome: Insights From a Multicenter Real-World Cohort Study

By afschroeder • July 11, 2026

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early Sodium-Glucose Cotransporter Two Inhibitor Use in Takotsubo Syndrome: Insights From a Multicenter Real-World Cohort Study. Am J Cardiol. 2026 Aug 1;272:95-102. doi: 10.1016/j.amjcard.2026.05.012. Epub 2026 May 16. PMID: 42144123.

Tags: Cardiology/Epi, Guideline-directed medical therapy, Heart failure with reduced ejection fraction, Publications, SGLT2 inhibitors, Stress cardiomyopathy, Takotsubo cardiomyopathy

Trends in Alcohol-Related Deaths in the United States Over 55 Years: 1968-2023

Zulfiqar M, Uddin MS, Abbas F, Sajjad A, Uddin A, Shah SAA, Fonarow GC, Waqas SA, Yokolo H, Qureshi S. Trends in Alcohol-Related Deaths in[...]

Delivering Quadruple Therapy for Heart Failure With Reduced Ejection Fraction in a Customizable Polypill: The COMBO-HF-X Pilot Randomized Trial

DeJong C, Durstenfeld MS, Davis JD, Wang CS, Riley ED, Huffman MD, Hickey MD, Shade SB, Chen JC, Kazi DS, Grochowski J, Steward WT, Zier[...]

A Unifying Model of Inflammatory Amplification: Insights From Colchicine Across Cardiometabolic and Infectious Disease

Rabbani AB. A Unifying Model of Inflammatory Amplification: Insights From Colchicine Across Cardiometabolic and Infectious Disease. Cureus. 2026 Jun 10;18(6):e110588. doi: 10.7759/cureus.110588. PMID: 42434640; PMCID:[...]